Skip to main content
Press Releases

COVID-19 Virus is Evolving to Get Better at Becoming Airborne, New Study Shows

Findings suggest need for better ventilation and tight-fitting masks, in addition to widespread vaccination, to help stop spread of the virus

Back to News
A person sits inside a booth called the Gesundheit II, which is used to collect their exhaled breath and test for virus transmission.
The Gesundheit II booth is used to capture exhaled breath of COVID-19 patients. SARS-CoV-2 is evolving toward more efficient aerosol generation, and loose-fitting masks provide significant but only modest source control. Until vaccination rates are very high, continued layered controls, including improved ventilation, increased filtration, UV air sanitation, and tight-fitting masks are critical to protect people in public-facing jobs and indoor spaces.

Results of a new study led by the University of Maryland School of Public Health show that people infected with the virus that causes COVID-19 exhale infectious virus in their breath – and those infected with the Alpha variant (the dominant strain circulating at the time this study was conducted) put 43 to 100 times more virus into the air than people infected with the original strains of the virus. The researchers also found that loose-fitting cloth and surgical masks reduced the amount of virus that gets into the air around infected people by about half. The study was published in Clinical Infectious Diseases.

“Our latest study provides further evidence of the importance of airborne transmission,” said Dr. Don Milton, professor of environmental health at the University of Maryland School of Public Health (UMD SPH). “We know that the Delta variant circulating now is even more contagious than the Alpha variant. Our research indicates that the variants just keep getting better at travelling through the air, so we must provide better ventilation and wear tight-fitting masks, in addition to vaccination, to help stop spread of the virus.”

The amount of virus in the air coming from Alpha variant infections was much more—18-times more—than could be explained by the increased amounts of virus in nasal swabs and saliva. One of the lead authors, doctoral student Jianyu Lai explained that, “We already knew that virus in saliva and nasal swabs was increased in Alpha variant infections. Virus from the nose and mouth might be transmitted by sprays of large droplets up close to an infected person. But, our study shows that the virus in exhaled aerosols is increasing even more.” These major increases in airborne virus from Alpha infections occurred before the Delta variant arrived and indicate that the virus is evolving to be better at travelling through the air.

To test whether face masks work in blocking the virus from being transmitted among people, this study measured how much SARS-CoV-2 is breathed into the air and tested how much less virus people sick with COVID-19 exhaled into the air after putting on a cloth or surgical mask. Face coverings significantly reduced virus-laden particles in the air around the person with COVID-19, cutting the amount by about 50%. Unfortunately, the loose-fitting cloth and surgical masks didn’t stop infectious virus from getting into the air. 

Dr. Jennifer German, a co-author said, “The take-home messages from this paper are that the coronavirus can be in your exhaled breath, is getting better at being in your exhaled breath, and using a mask reduces the chance of you breathing it on others.” This means that a layered approach to control measures (including improved ventilation, increased filtration, UV air sanitation, and tight-fitting masks, in addition to vaccination) is critical to protect people in public-facing jobs and indoor spaces. 

The study, Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection, was published in Clinical Infectious Diseases and conducted by researchers from the University of Maryland School of Public Health, University of Maryland School of Medicine, Walter Reed Army Institute of Research, Duke-NUS Medical School, and Rice University. 

 

 

 

 

  • Categories
  • Press Releases
  • Research
  • COVID-19
  • Departments
  • Global, Environmental, and Occupational Health